Clinical Trials

Overview

About this study

The purpose of this study is to evaluate whether newly developed acquisition techniques or 1.5 Tesla and 3.0 Tesla MRI scanners systems can provide improvements over current acquisition techniques. The objective of this protocol is to allow investigators to perform initial test evaluation in humans of new MRI acquisition techniques.  

All pulse sequences, including the ones that we testing, can be used on FDA-approved MRI scanners as long as they meet FDA guidelines for non-significant risk, and our new sequences all meet these guidelines.

All MRI test scans of new pulse sequences will be performed subject to FDA guidelines which have been determined to pose Non-Significant Risk.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Participating Mayo Clinic locations

More information